| I-42 Jennifer Hibma Population Pharmacokinetic/Pharmacodynamic Evaluation of the Effect of Inotuzumab Ozogamicin on QT Intervals in ALL and NHL Patients Wednesday 10:20-11:40 |
| I-42 Jennifer Hibma Population Pharmacokinetic/Pharmacodynamic Evaluation of the Effect of Inotuzumab Ozogamicin on QT Intervals in ALL and NHL Patients Wednesday 10:20-11:40 |